The Importance of Private Cord Blood Banking for Mixed-Race Families

Mixed-race children and ethnic minorities have a lower chance of finding a matching donor from a public cord blood bank. We explore how private cord blood banking can provide a practical solution for families who want to protect their child’s future health.

Did you know that for children of mixed race backgrounds or ethnic minorities, the chance of finding a matching donor from a public blood bank may be as low as 29%, compared with those from a white Caucasian background whose chance is 79%? (1)  

The disparity in these figures comes down to a range of genetic factors. Human leukocyte antigen markers, commonly known as HLA markers, are used by medical teams to predict a match between donor cells and a patient. Because these markers are inherited from both parents, a person’s ethnic backgrounds play a fundamental role. For children with mixed race heritage or parents from distinct racial groups, the resulting HLA combinations are far more diverse and unique. The demographics of public stem cell banks are constantly evolving, yet there remains a significant shortage of black, Asian and mixed race donors.  

While the NHS has made diversifying the donor base of the National Blood Service one of its top strategic priorities, there is still a long way to go to meet clinical demand. In adjacent healthcare areas, the challenge is just as visible. For example, recent figures from NHS Blood and Transplant show that people from ethnic minority backgrounds account for around 35% of the active transplant waiting list, despite making up roughly 18% of the UK population. (2)

The NHS Cord Blood Bank receives funding partly based on its efforts to build a more diverse inventory of cord blood units. This focus explains why around 42% of their donations derive from ethnic minorities, compared to just 8% on the Anthony Nolan register and 2% on the British Bone Marrow Registry. (3)

Even so, public cord blood banking within national healthcare systems faces clear logistical limitations. Public donation programmes rely on fixed collection centres, predominantly located around select London maternity hospitals where there is immediate access to a densely populated, ethnically diverse demographic. These structural constraints have resulted in matching rates of approximately 37% for black and ethnic minority patients, compared to 72% for Caucasian patients needing an unrelated donor. (4)

International registries face identical obstacles. In the United States, data shows comparable shortfalls for multi-ethnic patients seeking suitable bone marrow transplants or umbilical cord blood units. Because a perfect match is difficult to locate through public cord blood banks, families with multi-ethnic backgrounds often face prolonged waiting times during critical periods of medical care. (5)

Why do parents choose to bank their child’s cord blood?

Welcoming a new baby involves making dozens of practical preparations, and choosing whether to preserve a baby’s cord blood is an important personal decision for expectant parents. While nobody can foresee what health issues might emerge decades down the line, saving this unique biological material offers a proactive way to safeguard your immediate family.

Collecting your baby’s umbilical cord blood immediately after birth allows parents to preserve the valuable cord blood stem cells found inside. These include haematopoietic stem cells, which serve as the foundational building blocks for our blood and immune system. These primitive cells can develop into red blood cells, white blood cells, and platelets, making them a rich source of stem cells for ongoing treatments and clinical trials in regenerative medicine.

Today, cord blood stem cells are routinely used across the world in standard stem cell therapies for more than 80 diseases and conditions. Because stem cells are young and adaptable, they can help replace diseased tissue, regenerate damaged bone marrow, and repair functional cellular systems. Some examples of conditions or symptoms of conditions which can be treated using cord blood stem cell transplants are cerebral palsy, blood cancers such as leukaemia and lymphoma, Parkinson’s disease, genetic disorders such as thalassaemia and sickle cell disease, severe immune deficiencies, and bone marrow failure syndromes.

Medical research and stem cell research are also evaluating the role of cord blood in experimental treatments for cerebral palsy, autism spectrum disorders, Parkinson’s disease, and traumatic spinal cord injury.

For certain families, a known medical history or inherited genetic issue means they already understand their child could face specific health conditions in the future. For others, specific ethnic backgrounds bring a statistical predisposition to illnesses such as sickle cell disease, which is more prevalent among individuals of African, Caribbean, Mediterranean, Middle Eastern, and South Asian descent. In these circumstances, having stored cord blood gives healthcare providers immediate access to viable stem cell treatments without relying on an international registry search.

Many parents view the storage of umbilical cord blood as a sensible form of biological insurance. Knowing your child has an exact genetic match preserved from day one brings lasting peace of mind, especially when you know public registers may struggle to supply a suitable match.

Understanding public banks and private cord blood banks

When weighing up the options, it is helpful to understand the practical differences between public banking and private banking. Both models serve valuable purposes, but they operate under entirely distinct frameworks.

Public banks collect umbilical cord blood donations at no cost to the mother. Once donated, the sample belongs to the public bank. It is anonymised, tissue-typed, and listed on international registries for any patient across the globe who requires an umbilical cord blood transplant. While public donation is a generous civic contribution, you forfeit all rights to that unit. If your own child or another family member needs stem cells years later, there is no guarantee that original donation will be available or retained in storage.

In contrast, private cord blood banks store a child’s cord blood exclusively for that specific family’s use. Parents pay an initial fee for the collection kit, courier logistics, laboratory testing, and processing, followed by annual storage fees or a long-term storage package covering several decades. The stored cord blood remains your legal property, reserved entirely for your child or a compatible immediate family member.

When assessing the pros and cons of cord blood banking, medical organisations offer clear perspectives. Guidelines from professional bodies note that while public banks support wider community needs, private storage guarantees an autologous stem cell source reserved exclusively for the donor. Storing with reputable private banks or specialist services like Smart Cells ensures that families facing lower representation on public donor registers retain direct access to their own cord blood.

The difference between a partial match and an exact match carries real clinical weight, especially for mixed race families. When doctors have to use an adult donor with even a single mismatched tissue marker, long term patient outcomes decline notably. For mixed heritage families who already face steeper statistical hurdles on public registers, banking a child’s own cord blood provides a guaranteed, perfect genetic match for autologous treatments, completely removing the risks associated with tissue mismatching. When a patient has to settle for a 7/8 match because a perfect donor is not available on public registries, clinical studies show that five year survival rates drop by around eight percentage points. For mixed-race individuals, who already face lower odds of securing an 8/8 match publicly, having access to an autologous sample eliminates the risk of mismatch complications like graft versus host disease. (5)

You can find out more about public vs private cord blood banking here.

How to ensure your child has access to a match

If a patient must rely on an unrelated donor from a public cord blood bank, the process requires searching national and international donor databases to find a sample that shares sufficient human leukocyte antigen markers. Finding a close match reduces the risk of serious complications, including graft-versus-host disease, where the transplanted donor cells recognise the patient’s body as foreign and attack healthy tissue.

For families of mixed heritage, finding that match through a public blood bank is mathematically challenging. The most dependable method to ensure your child has an accessible, flawless match for autologous treatments is to store their own cord blood at birth with an accredited private blood bank like Smart Cells.

Using a child’s own cells for an autologous transplant eliminates the risk of graft-versus-host disease and bypasses the lengthy search for an unrelated donor. Autologous samples are used in treatments for specific solid tumours like neuroblastoma, spinal cord injury, cerebral palsy, and select regenerative therapies.

If a sibling requires stem cell treatment for an inherited blood disorder or leukaemia, stored sibling cord blood offers a higher chance of compatibility than searching a public register. Siblings sharing the same biological parents have a 25% chance of being a perfect match and an overall greater chance of providing a usable match than an unrelated stranger.

The practical advantages of private storage

Choosing a reliable private cord blood banking service ensures you have direct, fast access to your child’s stem cells without bureaucratic delays. When life-saving treatments are required, timing is critical, and waiting months for stem cell matches, medical clearances, and overseas transport can complicate patient care.

Smart Cells operates its primary UK laboratory and storage facility close to London Heathrow airport, allowing for prompt sample transport from maternity wards across the country and rapid dispatch internationally when needed. We work closely with maternity teams and healthcare providers across the UK, including leading private cord bank London maternity units, to ensure the cord blood collection is handled seamlessly alongside your birth plan.

Cord blood collection itself is entirely safe, non-invasive, and painless for both mother and newborn baby. It takes place immediately after the delivery of the baby and placenta, meaning it does not interfere in any way with your birthing process, standard obstetric care, or immediate skin-to-skin bonding. The procedure gathers the blood remaining within the umbilical cord and placenta that would otherwise be discarded as clinical waste.

Once collected, the sample is transferred directly to our laboratory, where our scientists extract the maximum concentration of viable baby’s stem cells. The cord blood stem cells are tested, cryogenically preserved in liquid nitrogen vapour, and maintained under rigorous quality standards. This guarantees that if medical advances or personal circumstances require the future use of those cells in twenty, thirty, or forty years, the maximum number of healthy, viable cells will be ready for clinical application.

Making the right choice for your family

Every family has unique circumstances, whether you are single parents planning ahead independently, parents from different ethnic backgrounds, or a family with a clear history of a specific medical condition or other blood disorders. Making an informed decision about your baby’s umbilical cord blood banking requires understanding both the capabilities of modern medicine and the realistic availability of healthy adults registering as public donors.

For mixed race and ethnic minority families, private storage of umbilical cord blood removes the uncertainty of public registries, ensuring that your child’s own unique biological resources are protected, secure, and ready whenever they might be needed.

Click here to find out more about what Smart Cells can offer to all families, and please do get in touch if we can help with any questions you have about cord blood banking.

(1) https://ij.org/wp-content/uploads/2023/09/Media-Fact-Sheet-2023-FINAL-1.pdf 

(2) https://nhsbtdbe.blob.core.windows.net/umbraco-assets-corp/37859/annual-report-on-ethnicity-differences-2024_2025.pdf 

(3) https://uwe-repository.worktribe.com/OutputFile/8539495 

(4) https://nhsbtdbe.blob.core.windows.net/umbraco-assets-corp/28283/a-10-year-vision-for-hsct-and-cellular-therapies-august-2022-8.pdf 

(5) https://www.nejm.org/doi/full/10.1056/NEJMsa1311707